Monoclonal Gammopathy of Undeterminated Significance and Endoneurial IgG Deposition: A Case Report

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2016 Sep 8

PMID 27603395

Citations 5

Authors

Stephane Mathis

Jerome Franques

Laurence Richard

Jean-Michel Vallat

Affiliations

Soon will be listed here.

Abstract

Background: Monoclonal gammopathy of undeterminated significance is the most common form of plasma cell dyscrasia, usually considered as benign. In rare cases it may have a malignant course, sometimes limited to an organ such as peripheral nerves.

Methods: We describe clinical, electrophysiological and pathological findings in a patient presenting a immunoglobulin G (IgG) paraproteinemic polyneuropathy clinically mimicking a chronic inflammatory demyelinating polyneuropathy.

Results: Immuno-electron microscopy (immune-EM) demonstrated that the widenings of the myelin lamellae resulted from the infiltration of IgG between a significant number of myelin lamellae (with absence of inflammatory cells in the epineurium, endoneurium, and perineurium, and the lack signs of vasculitis). This patient was finally treated successfully with lenalidomide then mycophenolate mofetil.

Conclusions: In polyneuropathies associated to a monoclonal gammopathy, a nerve biopsy may clinch the diagnosis. Immuno-EM may be required to determine the role of the pathological immunoglobulin in the destruction of the peripheral nerve parenchyma. Diagnosis of such a direct involvement of peripheral nerve can endorse more aggressive treatment of real efficiency.

Citing Articles

Monoclonal gammopathies of clinical significance (MGCS): In pursuit of optimal treatment.

Oganesyan A, Gregory A, Malard F, Ghahramanyan N, Mohty M, Kazandjian D Front Immunol. 2022; 13:1045002.

PMID: 36505449 PMC: 9728929. DOI: 10.3389/fimmu.2022.1045002.

Corneal Densitometry and In Vivo Confocal Microscopy in Patients with Monoclonal Gammopathy-Analysis of 130 Eyes of 65 Subjects.

Kormanyos K, Kovacs K, Nemeth O, Toth G, Sandor G, Csorba A J Clin Med. 2022; 11(7).

PMID: 35407456 PMC: 9000138. DOI: 10.3390/jcm11071848.

Ocular Signs and Ocular Comorbidities in Monoclonal Gammopathy: Analysis of 80 Subjects.

Kormanyos K, Kovacs K, Nemeth O, Toth G, Sandor G, Csorba A J Ophthalmol. 2021; 2021:9982875.

PMID: 34239724 PMC: 8235972. DOI: 10.1155/2021/9982875.

Nerve biopsy: Current indications and decision tools.

Nathani D, Spies J, Barnett M, Pollard J, Wang M, Sommer C Muscle Nerve. 2021; 64(2):125-139.

PMID: 33629393 PMC: 8359441. DOI: 10.1002/mus.27201.

Longitudinal extensive transverse myelitis with an abnormal uFLC ratio in a pediatric patient: Case report and literature review.

Hsu P, Chen S Medicine (Baltimore). 2018; 96(52):e9389.

PMID: 29384915 PMC: 6392810. DOI: 10.1097/MD.0000000000009389.

References

Kyle R, Therneau T, Rajkumar S, Larson D, Plevak M, Offord J . Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med. 2006; 354(13):1362-9. DOI: 10.1056/NEJMoa054494. View

Bedi G, Brown A, Tong T, Sharma K . Chronic inflammatory demyelinating polyneuropathy responsive to mycophenolate mofetil therapy. J Neurol Neurosurg Psychiatry. 2010; 81(6):634-6. DOI: 10.1136/jnnp.2009.177576. View

Bird J, Owen R, DSa S, Snowden J, Pratt G, Ashcroft J . Guidelines for the diagnosis and management of multiple myeloma 2011. Br J Haematol. 2011; 154(1):32-75. DOI: 10.1111/j.1365-2141.2011.08573.x. View

Kuijf M, Eurelings M, Tio-Gillen A, van Doorn P, van den Berg L, Hooijkaas H . Detection of anti-MAG antibodies in polyneuropathy associated with IgM monoclonal gammopathy. Neurology. 2009; 73(9):688-95. DOI: 10.1212/WNL.0b013e3181b59a80. View

Takebe N, Cheng X, Fandy T, Srivastava R, Wu S, Shankar S . IMP dehydrogenase inhibitor mycophenolate mofetil induces caspase-dependent apoptosis and cell cycle inhibition in multiple myeloma cells. Mol Cancer Ther. 2006; 5(2):457-66. DOI: 10.1158/1535-7163.MCT-05-0340. View

Vallat J, Magy L, Sindou P, Magdelaine C, Cros D . IgG neuropathy: an immunoelectron microscopic study. J Neuropathol Exp Neurol. 2005; 64(5):386-90. DOI: 10.1093/jnen/64.5.386. View

Duchesne M, Mathis S, Corcia P, Richard L, Ghorab K, Jaccard A . Value of nerve biopsy in patients with latent malignant hemopathy and peripheral neuropathy: a case series. Medicine (Baltimore). 2015; 94(3):e394. PMC: 4602630. DOI: 10.1097/MD.0000000000000394. View

Ramchandren S, Lewis R . An update on monoclonal gammopathy and neuropathy. Curr Neurol Neurosci Rep. 2011; 12(1):102-10. DOI: 10.1007/s11910-011-0237-4. View

Magy L, Chassande B, Maisonobe T, Bouche P, Vallat J, Leger J . Polyneuropathy associated with IgG/IgA monoclonal gammopathy: a clinical and electrophysiological study of 15 cases. Eur J Neurol. 2003; 10(6):677-85. DOI: 10.1046/j.1468-1331.2003.00687.x. View

10.

Vallat J, Magy L, Richard L, Sturtz F, Couratier P . Contribution of electron microscopy to the study of neuropathies associated with an IgG monoclonal paraproteinemia. Micron. 2007; 39(2):61-70. DOI: 10.1016/j.micron.2006.12.005. View

11.

Nobile-Orazio E, Casellato C, Di Troia A . Neuropathies associated with IgG and IgA monoclonal gammopathy. Rev Neurol (Paris). 2002; 158(10 Pt 1):979-87. View

12.

Keita M, Magy L, Richard L, Piaser M, Vallat J . LR white post-embedding colloidal gold method to immunostain MBP, P0, NF and S100 in glutaraldehyde fixed peripheral nerve tissue. J Peripher Nerv Syst. 2002; 7(2):128-33. DOI: 10.1046/j.1529-8027.2002.02013.x. View

13.

Vallat J, Jauberteau M, Bordessoule D, Yardin C, Preux P, Couratier P . Link between peripheral neuropathy and monoclonal dysglobulinemia: a study of 66 cases. J Neurol Sci. 1996; 137(2):124-30. DOI: 10.1016/0022-510x(95)00343-z. View

14.

Mathis S, Vallat J, Magy L . Novel immunotherapeutic strategies in chronic inflammatory demyelinating polyneuropathy. Immunotherapy. 2016; 8(2):165-78. DOI: 10.2217/imt.15.107. View

15.

. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of paraproteinemic demyelinating neuropathies. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve.... J Peripher Nerv Syst. 2010; 15(3):185-95. DOI: 10.1111/j.1529-8027.2010.00278.x. View

16.

Kyle R . Diagnostic criteria of multiple myeloma. Hematol Oncol Clin North Am. 1992; 6(2):347-58. View

17.

Vallat J, Tabaraud F, Sindou P, Preux P, Vandenberghe A, Steck A . Myelin widenings and MGUS-IgA: an immunoelectron microscopic study. Ann Neurol. 2000; 47(6):808-11. View

18.

Rossi F, Petrucci M, Guffanti A, Marcheselli L, Rossi D, Callea V . Proposal and validation of prognostic scoring systems for IgG and IgA monoclonal gammopathies of undetermined significance. Clin Cancer Res. 2009; 15(13):4439-45. DOI: 10.1158/1078-0432.CCR-08-3150. View

19.

Simmons Z, Albers J, Bromberg M, Feldman E . Long-term follow-up of patients with chronic inflammatory demyelinating polyradiculoneuropathy, without and with monoclonal gammopathy. Brain. 1995; 118 ( Pt 2):359-68. DOI: 10.1093/brain/118.2.359. View

20.

Dyck P, Low P, Windebank A, S Jaradeh S, Gosselin S, Bourque P . Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance. N Engl J Med. 1991; 325(21):1482-6. DOI: 10.1056/NEJM199111213252105. View